Download PDF
Aktuelle Neurologie 2015; 42(01): 50-51
DOI: 10.1055/s-0034-1387558
Kompetenznetz Multiple Sklerose
© Georg Thieme Verlag KG Stuttgart · New York

Aktuelles aus der Forschung

L. H. Klotz
1   Klinik für Allgemeine Neurologie, Department für Neurologie, Universitätsklinikum Münster
,
F. Then Bergh
2   Klinik und Poliklinik für Neurologie, Universität Leipzig
› Author Affiliations
Further Information

Publication History

Publication Date:
18 February 2015 (online)

Also available at
    Permissions and Reprints

Neue Erkenntnisse zu ernährungsbedingten Einflüssen bei MS

In den vergangenen Jahren ist die Bedeutung von Umweltfaktoren, unter anderem bestimmte Ernährungsgewohnheiten, für die Entstehung sowie den Krankheitsverlauf bei der Multiplen Sklerose (MS) immer mehr in den Vordergrund gerückt. Interessanterweise ist ein gesteigerter Salzkonsum über die Nahrung mit einem schwereren Krankheitsverlauf im Tiermodell der MS, der Experimentellen Autoimmunen Enzephalomyelitis (EAE), assoziiert [1]. Dies ist durch eine gesteigerte Entstehung einer bestimmten Lymphozytensubpopulation, der T-Helfer-17-Zellen (TH17) bedingt.

 

  • Literatur

  • 1 Kleinewietfeld M, Manzel A, Titze J et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013; 496: 518-522
    CrossrefPubMedGoogle Scholar
  • 2 Farez MF, Fiol MP, Gaitán MI et al. Sodium intake is associated with increased disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015; 86: 26-31
    CrossrefPubMedGoogle Scholar
  • 3 Hafler DA, Campston A, Sawcer S et al. International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862
    CrossrefPubMedGoogle Scholar
  • 4 Beecham AH, Patsopoulos NA, Xifara DK et al. International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360
    CrossrefPubMedGoogle Scholar
  • 5 Hartmann FJ, Khademi M, Aram J et al. Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells. Nat Commun 2014; 5: 5056
    CrossrefPubMedGoogle Scholar
  • 6 El Behi M, Ciric B, Dai H et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011; 12: 568-575
    CrossrefPubMedGoogle Scholar
  • 7 Dickens AM, Larkin JR, Griffin JL et al. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis. Neurology 2014; 83: 1492-1499
    CrossrefPubMedGoogle Scholar
  • 8 Giannetti P, Politis M, Su P et al. Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome. Brain 2015; 138: 110-119
    CrossrefPubMedGoogle Scholar
  • 9 Loizou CP, Petroudi S, Seimenis I et al. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome. J Neuroradiol 2014; Epub ahead of print: DOI: S0150-9861(14)00177-1.
    PubMedGoogle Scholar
  • 10 Bester M, Heesen C, Schippling S et al. Early anisotropy changes in the corpus callosum of patients with optic neuritis. Neuroradiology 2008; 50: 549-557
    CrossrefPubMedGoogle Scholar
  • 11 Wattjes MP, Harzheim M, Lutterbey GG et al. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology 2008; 50: 123-129
    CrossrefPubMedGoogle Scholar
  • 12 Brex PA, Leary SM, Plant GT et al. Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. AJNR Am J Neuroradiol 2001; 22: 947-951
    PubMedGoogle Scholar